Kastelein Johannes Jacob Pieter

NewAmsterdam Pharma Company N.V. ยท Chief Scientific Officer

Kastelein Johannes Jacob Pieter is listed in public filings as director, officer: Chief Scientific Officer. This Kastelein Johannes Jacob Pieter insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include NewAmsterdam Pharma Company N.V. (NAMS). Investors use Kastelein Johannes Jacob Pieter's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
NewAmsterdam Pharma Company N.V.NAMS$2.1M69.3k sharesSellMar 9, 2026$3.1M101.4k shares$30.29--
NewAmsterdam Pharma Company N.V.NAMS--170.7k sharesGrant / ExerciseMar 9, 2026Disclosure amount unavailable101.4k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
NewAmsterdam Pharma Company N.V.NAMS$2.1M69.3k sharesSellMar 6, 2026$2.9M94.1k shares$30.32--
NewAmsterdam Pharma Company N.V.NAMS--163.4k sharesGrant / ExerciseMar 6, 2026Disclosure amount unavailable94.1k shares----
NewAmsterdam Pharma Company N.V.NAMS$2.1M69.3k sharesSellMar 5, 2026$3.2M104.5k shares$30.30--
NewAmsterdam Pharma Company N.V.NAMS--173.8k sharesGrant / ExerciseMar 5, 2026Disclosure amount unavailable104.5k shares----
NewAmsterdam Pharma Company N.V.NAMS$1.9M53.5k sharesSellFeb 20, 2026$1.1M30.8k shares$35.46--
NewAmsterdam Pharma Company N.V.NAMS$3.0M84.3k sharesSellFeb 20, 2026$514.2K14.7k shares$35.00--
NewAmsterdam Pharma Company N.V.NAMS$4.1M115k sharesGrant / ExerciseJan 7, 2026$4.1M115k shares$35.45--
NewAmsterdam Pharma Company N.V.NAMS--99k sharesGrant / ExerciseJan 7, 2026Disclosure amount unavailable25.5k shares----
NewAmsterdam Pharma Company N.V.NAMS$2.4M73.5k sharesSellJan 5, 2026$199.5K6k shares$33.25--
NewAmsterdam Pharma Company N.V.NAMS$1.9M77k sharesSellAug 22, 2025$1.1M42.3k shares$25.08--
NewAmsterdam Pharma Company N.V.NAMS$1.8M69.3k sharesSellAug 22, 2025$195.2K7.7k shares$25.49--
NewAmsterdam Pharma Company N.V.NAMS$2.9M119.3k sharesSellAug 21, 2025$1.2M50k shares$24.29--
NewAmsterdam Pharma Company N.V.NAMS--45.5k sharesGrant / ExerciseMar 26, 2025Disclosure amount unavailable45.5k shares----
NewAmsterdam Pharma Company N.V.NAMS--45.5k sharesGrant / ExerciseMar 26, 2025Disclosure amount unavailable45.5k shares----
NewAmsterdam Pharma Company N.V.NAMS--169.3k sharesGrant / ExerciseMar 26, 2025Disclosure amount unavailable19.3k shares----
NewAmsterdam Pharma Company N.V.NAMS--150k sharesGrant / ExerciseMar 24, 2025Disclosure amount unavailable150k shares----
NewAmsterdam Pharma Company N.V.NAMS--34k sharesGrant / ExerciseJan 7, 2025Disclosure amount unavailable34k shares----
NewAmsterdam Pharma Company N.V.NAMS$5.2M200k sharesGrant / ExerciseJan 2, 2025$5.2M200k shares$25.96--